FDA Warns Philips After Plant Inspections

Law360, New York (April 22, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has warned Philips Medical Systems Inc. about problems with the company's procedures for documenting certain aspects of the business and production process, which the agency found during inspections of a plant in Cleveland.

In a letter sent to the company on April 1 that was publicly released Tuesday, the FDA said that problems remain even though many of the dozen or so problems originally last year have since been alleviated.

Inspectors visited the plant, which makes nuclear medicine devices and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.